Diode Low Reactive Level Laser Therapy and Stellate Ganglion Block Compared in the Treatment of Facial Palsy

Murakami, F; Kemmotsu, Osamu; Kawano, Yoichi; Matsumura, Chi; Kaseno, Shigeo; Imai, Makoto

doi:10.5978/islsm.93-or-15

Cited by 18 publications

(20 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The final sample consisted of nine randomized placebo- or active-controlled [40, 43–50] and four quasi-randomized [51–54] trials published between 1994 and 2014 with a total sample size of 440 patients.…”

Section: Resultsmentioning

confidence: 99%

“…Of the 13 trials, six reported co-interventions, with one using physical therapy [44], three allowing pharmacological medication [47, 50, 51], and two combining physical therapy and medication as a between-group co-intervention [40, 43]. With regard to treated conditions, patients with neuropathic pain disorders, namely CRPS type I [40, 43, 44, 46, 53], glossodynia [52], and postherpetic neuralgia [49], were treated in seven trials; patients with atypical facial palsy [50, 51, 54] were treated in three trials; patients with conditions related to sympathetic cardiovascular changes following a coronary artery bypass graft surgery [47] or a hysterectomy [48] were treated in two trials; and patients with posttraumatic hypothermia-related vasoconstriction were treated in one trial by applying TENS on the area near the stellate ganglion [45].…”

Section: Resultsmentioning

confidence: 99%

“…The medium-term follow-up of clinical outcomes 3 months after the end of the treatment protocol was reported in three trials [50, 51, 54]. None of the included trials reported long-term outcomes.…”

Section: Resultsmentioning

confidence: 99%

“…The third assessor determined the PEDro score of the remaining four trials [47, 51–53]. The interrater reliability associated with the cumulative PEDro score was acceptable with an intraclass correlation coefficient of 0.98 (95% CI: 0.94–0.99).…”

Section: Resultsmentioning

confidence: 99%

“…Noninvasive SGB can provide clinically effective pain relief, improve peripheral vasomotor and sudomotor dysfunction and abnormal heart rate variability (HRV), and maintain homeostasis in patients with neuropathic pain syndromes such as CRPS [40, 41, 43, 44, 46, 53, 57], fibromyalgia [33], glossodynia [52], burning mouth syndrome [31, 36, 58], postherpetic neuralgia [49, 59, 60], trigeminal neuralgia [61], and thalamic pain [55] as well as in those with other disorders such as Bell’s palsy [50, 51, 60], musculoskeletal pain [38], postoperative sensory disturbance [62], Raynaud’s phenomenon [63], glaucoma [64], and sudden deafness [65]. In addition, noninvasive SGB can alleviate conditions associated with hypersympathetic tone [35, 45, 47, 64–68] and physiological changes associated with suppressed sympathetic activities in healthy adults [34, 37, 42, 56, 69–75].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Efficacy of Noninvasive Stellate Ganglion Blockade Performed Using Physical Agent Modalities in Patients with Sympathetic Hyperactivity-Associated Disorders: A Systematic Review and Meta-Analysis

et al. 2016

View full text Add to dashboard Cite

BackgroundStellate ganglion blockade (SGB) is mainly used to relieve symptoms of neuropathic pain in conditions such as complex regional pain syndrome and has several potential complications. Noninvasive SGB performed using physical agent modalities (PAMs), such as light irradiation and electrical stimulation, can be clinically used as an alternative to conventional invasive SGB. However, its application protocols vary and its clinical efficacy remains controversial. This study investigated the use of noninvasive SGB for managing neuropathic pain or other disorders associated with sympathetic hyperactivity.Materials and MethodsWe performed a comprehensive search of the following online databases: Medline, PubMed, Excerpta Medica Database, Cochrane Library Database, Ovid MEDLINE, Europe PubMed Central, EBSCOhost Research Databases, CINAHL, ProQuest Research Library, Physiotherapy Evidence Database, WorldWideScience, BIOSIS, and Google Scholar. We identified and included quasi-randomized or randomized controlled trials reporting the efficacy of SGB performed using therapeutic ultrasound, transcutaneous electrical nerve stimulation, light irradiation using low-level laser therapy, or xenon light or linearly polarized near-infrared light irradiation near or over the stellate ganglion region in treating complex regional pain syndrome or disorders requiring sympatholytic management. The included articles were subjected to a meta-analysis and risk of bias assessment.ResultsNine randomized and four quasi-randomized controlled trials were included. Eleven trials had good methodological quality with a Physiotherapy Evidence Database (PEDro) score of ≥6, whereas the remaining two trials had a PEDro score of <6. The meta-analysis results revealed that the efficacy of noninvasive SGB on 100-mm visual analog pain score is higher than that of a placebo or active control (weighted mean difference, −21.59 mm; 95% CI, −34.25, −8.94; p = 0.0008).ConclusionsNoninvasive SGB performed using PAMs effectively relieves pain of various etiologies, making it a valuable addition to the contemporary pain management armamentarium. However, this evidence is limited by the potential risk of bias.

show abstract